PortfoliosLab logoPortfoliosLab logo
IBDRY vs. GNOM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

IBDRY vs. GNOM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Iberdrola SA (IBDRY) and Global X Genomics & Biotechnology ETF (GNOM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, IBDRY achieves a 13.32% return, which is significantly lower than GNOM's 14.90% return.


IBDRY

1D
-0.37%
1M
6.27%
YTD
13.32%
6M
14.04%
1Y
30.03%
3Y*
30.08%
5Y*
19.26%
10Y*
20.87%

GNOM

1D
0.90%
1M
12.22%
YTD
14.90%
6M
11.42%
1Y
61.83%
3Y*
2.88%
5Y*
-11.06%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

IBDRY vs. GNOM - Yearly Performance Comparison


2026 (YTD)2025202420232022202120202019
IBDRY
Iberdrola SA
13.32%65.75%10.02%17.36%3.59%-15.13%44.34%18.19%
GNOM
Global X Genomics & Biotechnology ETF
14.90%18.65%-15.99%-8.63%-36.27%-15.93%51.52%2.03%

Correlation

The correlation between IBDRY and GNOM is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.22

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (All Time)
Calculated using the full available price history since Apr 10, 2019

0.27

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

IBDRY vs. GNOM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

IBDRY
IBDRY Risk / Return Rank: 8484
Overall Rank
IBDRY Sharpe Ratio Rank: 8585
Sharpe Ratio Rank
IBDRY Sortino Ratio Rank: 8181
Sortino Ratio Rank
IBDRY Omega Ratio Rank: 8282
Omega Ratio Rank
IBDRY Calmar Ratio Rank: 8585
Calmar Ratio Rank
IBDRY Martin Ratio Rank: 8585
Martin Ratio Rank

GNOM
GNOM Risk / Return Rank: 6868
Overall Rank
GNOM Sharpe Ratio Rank: 7676
Sharpe Ratio Rank
GNOM Sortino Ratio Rank: 7474
Sortino Ratio Rank
GNOM Omega Ratio Rank: 6363
Omega Ratio Rank
GNOM Calmar Ratio Rank: 7171
Calmar Ratio Rank
GNOM Martin Ratio Rank: 5858
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

IBDRY vs. GNOM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Iberdrola SA (IBDRY) and Global X Genomics & Biotechnology ETF (GNOM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


IBDRYGNOMDifference
Sharpe ratioReturn per unit of total volatility

-0.55

Sortino ratioReturn per unit of downside risk

-0.82

Omega ratioGain probability vs. loss probability

1.31

1.36

-0.05

Calmar ratioReturn relative to maximum drawdown

3.29

3.42

-0.13

Martin ratioReturn relative to average drawdown

8.40

9.81

-1.41

IBDRY vs. GNOM - Sharpe Ratio Comparison

The current IBDRY Sharpe Ratio is 1.72, which is comparable to the GNOM Sharpe Ratio of 2.28. The chart below compares the historical Sharpe Ratios of IBDRY and GNOM, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

IBDRY vs. GNOM - Drawdown Comparison

The maximum IBDRY drawdown since its inception was -77.08%, roughly equal to the maximum GNOM drawdown of -75.00%. Use the drawdown chart below to compare losses from any high point for IBDRY and GNOM.


Loading charts...

Drawdown Indicators


IBDRYGNOMDifference

Max Drawdown

Largest peak-to-trough decline

-77.08%

-75.00%

-2.08%

Max Drawdown (1Y)

Largest decline over 1 year

-9.17%

-18.17%

+9.00%

Max Drawdown (3Y)

Largest decline over 3 years

-19.11%

-44.24%

+25.13%

Max Drawdown (5Y)

Largest decline over 5 years

-26.79%

-72.29%

+45.50%

Max Drawdown (10Y)

Largest decline over 10 years

-37.43%

Current Drawdown

Current decline from peak

-0.37%

-52.52%

+52.15%

Average Drawdown

Average peak-to-trough decline

-29.41%

-40.63%

+11.22%

Ulcer Index

Depth and duration of drawdowns from previous peaks

3.58%

6.32%

-2.74%

Volatility

IBDRY vs. GNOM - Volatility Comparison

The current volatility for Iberdrola SA (IBDRY) is 4.89%, while Global X Genomics & Biotechnology ETF (GNOM) has a volatility of 9.34%. This indicates that IBDRY experiences smaller price fluctuations and is considered to be less risky than GNOM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


IBDRYGNOMDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.89%

9.34%

-4.45%

Volatility (6M)

Calculated over the trailing 6-month period

13.74%

20.57%

-6.83%

Volatility (1Y)

Calculated over the trailing 1-year period

17.68%

27.29%

-9.61%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

21.35%

33.68%

-12.33%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

22.99%

34.17%

-11.18%

Dividends

IBDRY vs. GNOM - Dividend Comparison

IBDRY's dividend yield for the trailing twelve months is around 3.25%, more than GNOM's 1.20% yield.


PositionTTM20252024202320222021202020192018201720162015
GNOM
Global X Genomics & Biotechnology ETF
1.20%1.37%0.00%0.00%0.00%0.03%0.14%0.00%0.00%0.00%0.00%0.00%
IBDRY
Iberdrola SA
3.25%4.18%4.38%4.11%4.14%3.77%2.83%3.01%3.76%7.28%10.00%1.71%

Frequently Asked Questions


IBDRY and GNOM have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

GNOM has higher volatility (9.34%) compared to IBDRY (4.89%). In terms of maximum drawdown, IBDRY dropped -77.08% vs GNOM's -75.00%.

GNOM currently has the higher Sharpe Ratio (2.28 vs 1.72), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for IBDRY and GNOM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer